Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation (TAVIPSYCH)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the neuropsychological effects of transvascular aortic valve implantation (TAVI). Patients undergoing TAVI usually suffer from congestive heart failure and low cardiac output which may limit their cognitive abilities. TAVI results in significant improvements in cardiac function and therefore may improve cognitive functions. However, TAVI may also be associated with stroke and may therefore have a negative impact on cognition. Therefore, in this study the investigators wish to perform a battery of standardized neuropsychological tests before and after TAVI to test the net effects of TAVI on cognitive performance over time.
The investigators plan to include all patients planned to have TAVI in the study and to test them before, 3,7, 30 and 360 days post TAVI with a standardized battery of test.
| Condition | Intervention |
|---|---|
|
Aortic Stenosis |
Other: Neuropsychological testing |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Neuropsychological Testing in Patients Undergoing TAVI |
- net change in neuropsychological tests between baseline and day 180 from TAVI [ Time Frame: 180 days ] [ Designated as safety issue: No ]The study will assess changes in cognitive performance between baseline (prior to TAVI) and 180 days after TAVI
- net difference between cognitive measures before TAVI and at day 30 after TAVI [ Time Frame: 30 days ] [ Designated as safety issue: No ]The study will evaluate net differences between scores obtained on cognitive tests at baseline prior to TAVI and day 30 after TAVI
| Estimated Enrollment: | 70 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | September 2014 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
TAVI
patients with significant aortic stenosis that are candidates for transvascular aortic valve implantation
|
Other: Neuropsychological testing
This is an observational study
|
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
All patients with severe aortic stenosis that are candidates for TAVI
Inclusion Criteria:
- All patients with severe aortic stenosis that are candidates for TAVI
- Able to perform the testing
- Able to sign informed consent
Exclusion Criteria:
- Language barriers precluding the administration of the testing
- Existing dementia
- Existing disease limiting life expectancy to less than 180 days
Contacts and Locations| Contact: Ronen R Leker, MD | 9722677192 | leker@hadassah.org.il |
| Contact: Haim Danenberg, MD | danen@hadassah.org.il |
| Israel | |
| Hadassah Medical Center | Recruiting |
| Jerusalem, Israel, 91120 | |
| Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il | |
| Sub-Investigator: Haim Danenberg, MD | |
| Principal Investigator: | Ronen R Leker, MD | Hadassah Medical Organization |
More Information
No publications provided
| Responsible Party: | Ronen Leker, Director - Stroke Center, Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT01648309 History of Changes |
| Other Study ID Numbers: | TAVIPSYCH-HMO-CTIL, TAVI registry Hadassah, TAVI registry Hadassah |
| Study First Received: | July 16, 2012 |
| Last Updated: | March 19, 2013 |
| Health Authority: | Israel:Ministry of Health - Director General |
Keywords provided by Hadassah Medical Organization:
|
aortic stenosis TAVI neuropsychological cognitive candidates for TAVI |
Additional relevant MeSH terms:
|
Aortic Valve Stenosis Constriction, Pathologic Heart Valve Diseases Heart Diseases |
Cardiovascular Diseases Ventricular Outflow Obstruction Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 19, 2013